This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ferro, D. Articles by Violi, F. Search for Related Content PubMed PubMed Citation Articles by Ferro, D. Articles by Violi, F.

Stroke, Vol 24, 368-370, Copyright © 1993 by American Heart Association

ARTICLES

Lupus anticoagulant and the fibrinolytic system in young patients with stroke

D Ferro, C Quintarelli, M Rasura, G Antonini and F Violi
Istituto di I Clinica Medica, University of Rome, Italy.

BACKGROUND AND PURPOSE: Our purpose was to assess the presence of lupus anticoagulant and fibrinolytic system abnormalities in young patients with stroke. METHODS: We studied 33 consecutive ischemic patients aged < 50 years. Lupus anticoagulant was screened by four different coagulation tests, and the fibrinolytic system was studied by analyzing tissue plasminogen activator antigen and plasminogen activator inhibitor activity. RESULTS: Six patients (18%), two of whom were affected by systemic lupus erythematosus, had lupus anticoagulant. Plasminogen activator inhibitor activity was significantly higher in those positive for lupus anticoagulant than in those negative for lupus anticoagulant and control subjects (p < 0.001). CONCLUSIONS: In young patients with stroke, lupus anticoagulant is associated with an imbalance of the fibrinolytic system as a result of higher levels of plasminogen activator inhibitor.